Emerging gene therapies for cystic fibrosis (2019)
Attributed to:
Development of a novel, potent, safe, long-lasting lentivirus-based gene therapy for cystic fibrosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/17476348.2019.1634547
PubMed Identifier: 31215818
Publication URI: http://europepmc.org/abstract/MED/31215818
Type: Journal Article/Review
Parent Publication: Expert Review of Respiratory Medicine
Issue: 8
ISSN: 1747-6348